Skip to content

Role of boger boenninghausen’s characteristics and repertory in homoeopathic management of hyperuricemia.

Usefulness of boger boenninghausen’s characteristics and repertory in homoeopathic management of hyperuricemia by considering rubric uric acid diathesis a prospective single arm pre post clinical study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078222
Enrollment
35
Registered
2024-12-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E79- Disorders of purine and pyrimidinemetabolism

Interventions

Intervention1: Homoeopathic medicine : Pill form 30 size pills oral route of administration centesimal scale first dose at the time of case taking subsequent doses according to follow ups upto 6 month

Sponsors

Bakson Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants of age group 18-59 year Male with SUA level more than 7 mg/dl and female with more than 6.0 mg/dl Participants willing to give consent will be included Uric acid diathesis as Eliminating Rubric

Exclusion criteria

Exclusion criteria: Participants with unstable mental or psychiatric diseases, uncontrolled or severe systemic illnesses, substance abuse, severe endocrine disorders, and already receiving homeopathic treatment for any chronic condition for past 3 months Pregnant and lactating females Recurrent case of renal stone

Design outcomes

Primary

MeasureTime frame
It is expected that there will be reduction in serum uric acid level of patients. There will be improvement in patient’s outcome without any substantial medical adverse effect hence a significant reduction in serum uric acid level is expected as compared to baseline and at 6 months. Timepoint: 15 months study Enrollment – 6 months follow up – 6 months Statistical analysis – 3 months first dose after case taking subsequent doses as per follow ups

Secondary

MeasureTime frame
NILTimepoint: Not Applicable

Countries

India

Contacts

Public ContactDr Ashwini Nair

Bakson Homoeopathic Medical College and Hospital

dr.neha678@gmail.com9899198690

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026